Clinical pharmacokinetics of oral acyclovir in patients on continuous ambulatory peritoneal dialysis?

Nephron

Volumn 74, Issue 2, 1996, Pages 337-341

  Stathoulopoulou, F ^a   Almond, M K ^b   Dhillon, S ^a   Raftery, M J ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Acyclovir; Continuous ambulatory peritoneal dialysis; Neurotoxicity

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER MODEL; COMPUTER PROGRAM; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG BLOOD LEVEL; FEMALE; HUMAN; KIDNEY FAILURE; MALE; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK;

EID: 0029794438     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189332     Document Type: Article

References (36)

1. Vanholder R. Ringoir S: Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review. J Am Soc Nephrol 1993;3:1541-1554.
2. Hakim RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993;4:484-494.
3. Haziot A. Chen S. Fcrrero E, Low M, Silber R. Goycrt S: The monocyte differentiation antigen. CD 14. is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988;141:547-552.
4. Bazil V, Horejsi V, Baudys M. Kristofova H. Strominger JL. Kostka W. Hilgert I: Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol 1986;16:1583-1589.
5. Wright SD, Ramos RA, Tobias PS, Ulcvitch RJ. Mathison JC: CD 14. a receptor for complexes of lipopolysaccharide (LPS) and EPS binding protein. Science 1990:249:1431-1433.
6. Dentencr MA. Bazil V. Von Asmulh EJU. C'cs-ka M. Buurman WA: Involvement of CD 14 in lipopolysaccharidc-induced tumor necrosis factor-a. interleukin-6 and interleukin-8 release by human monocytes and alveolar macrophages. J Immunol 1993;150:2885-2891.
7. Couturier C, Jalms G. Kazatchkine MD, Haeffncr-Cavaillon N: Membrane molecules which trigger the production of interleukin-1 and tumor necrosis faclor-a by lipopolvsaccha-ride-stimulated human monocytes. Eur J Immunol 1992;22:1461-1466.
8. Beekhuizen H. Blokland I. Corsel-van Tilburg AJ. Koning F. van Furth R: C'D14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J Immunol 1991:147:3761-3767.
9. Lynn WA. Raetz CRH. Qureshi N. Golenbock DT: Lipopolysaccharidc-induccd stimulation of CD1 lb/CD18 expression on neutrophils. J Immunol 1991;147:3072-3079.
10. Oharbonncau H. Tonks NK. Walsh KA. Fischer EH: The leukocyte common antigen (CD45): A putative receptor-linked protein tyrosine phosphatase. Proc Natl Acad Sei USA 1988:85:7182-7186.
11. Ledbetter JA. Tonks NK. Fischer F.H. Clark EA: CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells. Proc Natl Acad Sei USA 1988;85:8628-8632.
12. Harvath L. Balke JA. Christiansen NP. Russell AA, Skubitz KM: Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis. J Immunol 1991:146: 949-957.
13. Corvaia N, Reischl I. Krocmcr E. Mudde G: Modulation of Fc gamma receptor-mediated early events by the tyrosine phosphatase C'D45 in primary human monocytes. Consequences for IL-6 production. Eur J Immunol 1995,25: 738-744.
14. Vanholder R. Hoenich N. Ringoir S: Adequacy studies of fistula single-needle dialysis. Am J Kidney Dis 1987;10:417-426.
15. Vanholder R. Dcll'Aquila R, Jacobs V. Dhondt A. Veys N. Waterloos M. Van Landschoot N. Van Biesen W. Ringoir S: Depressed phagocytosis in hemodialvzed patients: in vivo and in vitro mechanisms. Nephron 1993:63:409-415.
16. Vanholder R. Ringoir S. Dhondt A. Hakim R: Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991:39:320-327.
17. Himmclfarb J, Lazarus JM. Hakim R: Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis. Am J Kidney Dis 1991; 17:271-276.
18. Pulido R. Alvarez V. Mollinedo F. Sanehez-Madrid F: Biochemical and functional characterization of the leukocyte tyrosine phosphatase CD45 (CD45RO. 180 kD) from human neutrophils. In vivo upregulation of CD45RO plasma membrane expression on patients undergoing haemodialysis. Clin Exp Immunol 1992;87:329-335.
19. Bazil V. Strominger JL: Shedding as a mechanism of down-modulation of CD 14 on stimulated human monocytes. J Immunol 1991:147: 1567-1574.
20. Marchant A, Duchow J. Delville JP. Goldman M: Lipopolysaccharide induces upregulation of CD 14 molecule on monocytes in human whole blood. EurJ Immunol 1992;22:1663-1665.
21. Levin NW. Zasuwa G. Dumler F: Effect of membrane type on causes of death in hemodialysis patients (abstract). J Am Soc Nephrol 1991:2:335.
22. Hornberger JC. Chemew M. Peterson J. Garber AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992;3:1227-1237.
23. Hakim RM. Wingard RL. Parker RA, Vanholder R. Husni L. Parker TF: Effects of bio-compatibilitv on hospitalizations and infectious morbidity in chronic hemodialysis patients (abstract). J Am Soc Nephrol 1994:5: 450.
24. Schiff] H. Lang SM. König A. Strasscr T. Haider MC. Held E: Biocompatiblc membranes in acute renal failure: prospective case-controlled study. Lancet 1994:344:570-572.
25. Nguyen AT, Lctltias C, Zingra lT J, Hcrbclin A, Naret C. Descamps-Lalscha B: Hemodialysis mcmbranc-induccd activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood. Kidney Int 1985:28:158-167.
26. Hörl Wl I. Steinhaucr HB, Schollmeycr P: Plasma levels of granulocyte clastase during hemodialysis: Effect of different dialyzcr membranes. Kidney Int 1985:28:791-796.
27. MacGregor RR: Granulocyte adherence changes induced by hemodialysis, endotoxin, epinephrine, and glucocorticoids. Ann Intern Med 1977;86:35-39.
28. Arnaout MA. Hakim RM, Todd RF. Dana N. Coltcn HR: Increased expresson of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 1985:312:457-462.
29. Himmclfarb J. Zaoui P. Hakim R: Modulation of granulocyte LAM-1 and MAC-1 during dialysis-A prospective, randomized controlled trial. Kidney Int 1992:41:388-395.
30. Thylcn P. Lundahl J. Fcrnvik E. lied J. Svcn-son SB, Jacobson SH: Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol 1992:12:393-400.
31. Lundhal J. Hed J. Jacobson SH: Dialysis granulocytopenia is preceded by an increased surface expression of the adhesion-promoting glu-coprctein Mac-1. Nephron 1992:61:163-169.
32. Tielemans C. Dclvillc J-P, l lusson C. Mad-houn P. Lambrechts A, Goldman M. Vanhcr-wcglicm J-L: Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol 1993:39:158-165.
33. Lee J. Hakim RM, Fearon DT: Increased expression of the C3b receptor by neutrophils and complement activation during haemodialvsis. Clin Exp Immunol 1984:56:205-214.
34. Schiller B. Zieglcr-Heitbrock HWL. Meyer N. Schmidt B. Blumenstein M: Monocyte phenotype and interleukin-l production in patients undergoing haemodialysis. Nephron 1991:59: 573-579.
35. Craddock PR. Fehr J. Delmasso AP. Brigham KL, Jacobs HS: Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialvzer cellophane membranes. J Clin Invest 1977:59:878-888.
36. Kcshaviah PR: Pretreatment and preparation of citywater for hemodialysis; in Maher JF (ed): Replacement of Renal Function by Dialysis, ed 3. Dordrecht, Kluwer Academic, 1989, pp 189-198.